{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:43:25Z","timestamp":1770813805649,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04192-0","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T12:05:12Z","timestamp":1744373112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-5403","authenticated-orcid":false,"given":"Ka\u011fan","family":"Cing\u00f6z","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-0722","authenticated-orcid":false,"given":"G\u00fcls\u00fcm","family":"Gen\u00e7o\u011flan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"10281","key":"4192_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN (2021) Psoriasis Lancet 397(10281):1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Psoriasis Lancet"},{"issue":"5","key":"4192_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361(5):496\u2013509. https:\/\/doi.org\/10.1056\/NEJMra0804595","journal-title":"N Engl J Med"},{"issue":"3","key":"4192_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM (2017) Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 76(3):377\u2013390. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.064","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"4192_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/joim.13227","volume":"289","author":"IM Skoie","year":"2021","unstructured":"Skoie IM, Ternowitz T, Jonsson G, Norheim K, Omdal R (2021) Psoriasis: more than skin deep. J Intern Med 289(6):770\u2013783. https:\/\/doi.org\/10.1111\/joim.13227","journal-title":"J Intern Med"},{"issue":"1","key":"4192_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/09546634.2020.1764904","volume":"33","author":"B Strober","year":"2022","unstructured":"Strober B, Menter A, Leonardi C, Gordon K, Lambert J, Puig L, Chiricozzi A, Mallbris L, Lebwohl M (2022) Efficacy and safety of biologics in the treatment of moderate to severe plaque psoriasis: a review of 10-year experience at the psoriasis treatment center of central Connecticut. J Dermatolog Treat 33(1):288\u2013301. https:\/\/doi.org\/10.1080\/09546634.2020.1764904","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"4192_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DL, Kaufmann J, Lebwohl M, Lim HW, Mehta NN, Paller AS, Schwarzenberger K, Summey BT, Wong EB, Wu JJ, Hariharan V, Elmets CA (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol 80(4):1029\u20131072. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.057","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4192_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1468-3083.2010.03537.x","volume":"24","author":"S Coimbra","year":"2010","unstructured":"Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A (2010) C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 24(7):789\u2013796. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03537.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"4192_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","volume":"150","author":"P Rocha-Pereira","year":"2004","unstructured":"Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F (2004) The inflammatory response in mild and in severe psoriasis. Br J Dermatol 150(5):917\u2013928. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05984.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"4192_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/15569527.2013.834498","volume":"33","author":"BB Sen","year":"2014","unstructured":"Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N (2014) Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol 33(3):223\u2013227. https:\/\/doi.org\/10.3109\/15569527.2013.834498","journal-title":"Cutan Ocul Toxicol"},{"issue":"11","key":"4192_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/1346-8138.13910","volume":"44","author":"A Asahina","year":"2017","unstructured":"Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H (2017) Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics. J Dermatol 44(11):1112\u20131121. https:\/\/doi.org\/10.1111\/1346-8138.13910","journal-title":"J Dermatol"},{"issue":"2","key":"4192_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/turkderm.57058","volume":"49","author":"M Unal","year":"2015","unstructured":"Unal M, Kucuk A, Unal GU, Balevi S, Tol H, Akyol M (2015) Mean platelet volume, neutrophil to lyphocyte ratio and platelet to lymphocyte ratio in psoriasis. Turkderm 49(2):112\u2013116. https:\/\/doi.org\/10.4274\/turkderm.57058","journal-title":"Turkderm"},{"issue":"4","key":"4192_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.5798\/diclemedj.0921.2016.04.0713","volume":"43","author":"BC Cemil","year":"2016","unstructured":"Cemil BC, Atas H (2016) The effect of biological treatment onto systemic inflammatory markers and plateletcrit in psoriasis patients. Dicle Med J 43(4):477\u2013483. https:\/\/doi.org\/10.5798\/diclemedj.0921.2016.04.0713","journal-title":"Dicle Med J"},{"issue":"4","key":"4192_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011) The \u2018psoriatic March\u2019: a concept of how severe psoriasis May drive cardiovascular comorbidity. Exp Dermatol 20(4):303\u2013307. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x","journal-title":"Exp Dermatol"},{"issue":"3","key":"4192_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5530\/ijmedph.3.2011.6","volume":"1","author":"A Lateef","year":"2011","unstructured":"Lateef A, Mohanty S, Reddy D, Rao PKS, Anand K, Rajesh S (2011) Atherogenic index and proteinfractions in psoriasis. Int J Med Pubic Health 1(3):25\u201330. https:\/\/doi.org\/10.5530\/ijmedph.3.2011.6","journal-title":"Int J Med Pubic Health"},{"issue":"2","key":"4192_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.23736\/S0392-0488.17.05545-0","volume":"153","author":"A Zangrilli","year":"2018","unstructured":"Zangrilli A, Bavetta M, Scaramella M, Schiavetti R, Cesaroni GM, Saraceno R, Bianchi L, Chimenti S (2018) Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low atherogenic index. G Ital Dermatol Venereol 153(2):146\u2013154. https:\/\/doi.org\/10.23736\/S0392-0488.17.05545-0","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"4192_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","volume":"71","author":"CI Daien","year":"2012","unstructured":"Daien CI, Duny Y, Barnetche T, Daur\u00e8s JP, Combe B, Morel J (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71(6):862\u2013868. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201148","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4192_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0394632017714698","volume":"30","author":"A Corrado","year":"2017","unstructured":"Corrado A, Di Bello V, d\u2019Onofrio F, Maruotti N, Cantatore FP (2017) Anti-TNF-alpha effects on anemia in rheumatoid and psoriatic arthritis. Int J Immunopathol Pharmacol 30(3):302\u2013307. https:\/\/doi.org\/10.1177\/0394632017714698","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2\u20133","key":"4192_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000243791","volume":"122","author":"E Nemeth","year":"2009","unstructured":"Nemeth E, Ganz T (2009) The role of Hepcidin in iron metabolism. Acta Haematol 122(2\u20133):78\u201386. https:\/\/doi.org\/10.1159\/000243791","journal-title":"Acta Haematol"},{"issue":"6","key":"4192_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4103\/0019-5154.143560","volume":"59","author":"N Dilek","year":"2014","unstructured":"Dilek N, Dilek AR, Sahin K, Bayram Y, Aral Y (2014) Hepcidin expression in psoriasis patients. Indian J Dermatol 59(6):630. https:\/\/doi.org\/10.4103\/0019-5154.143560","journal-title":"Indian J Dermatol"},{"issue":"5","key":"4192_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jaad.2008.12.006","volume":"60","author":"AM Brunasso","year":"2009","unstructured":"Brunasso AM, Massone C (2009) Thrombocytopenia associated with the use of anti-tumor necrosis factor-alpha agents for psoriasis. J Am Acad Dermatol 60(5):781\u2013785. https:\/\/doi.org\/10.1016\/j.jaad.2008.12.006","journal-title":"J Am Acad Dermatol"},{"key":"4192_CR21","doi-asserted-by":"publisher","first-page":"020","DOI":"10.23937\/2469-5696\/1410020","volume":"3","author":"VC Pereira","year":"2016","unstructured":"Pereira VC, Costa KH, De Oliveira LR (2016) Chronic use of adalimumab as potential cause of severe thrombocytopenia in psoriatic arthritis patient: the need for regular monitoring of cytopenias. Int J Blood Res Disord 3:020. https:\/\/doi.org\/10.23937\/2469-5696\/1410020","journal-title":"Int J Blood Res Disord"},{"issue":"8","key":"4192_CR22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.humpath.2015.05.001","volume":"46","author":"A Covach","year":"2015","unstructured":"Covach A, Husserl T, Winter JN, Rosen ST, Gordon LI (2015) A unique CD4\u2009+\u2009large granular lymphocytosis occurring in patients treated with tumor necrosis factor alpha inhibitors: report of 2 cases. Hum Pathol 46(8):1237\u20131241. https:\/\/doi.org\/10.1016\/j.humpath.2015.05.001","journal-title":"Hum Pathol"},{"issue":"2","key":"4192_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00296-006-0179-3","volume":"27","author":"A Theodoridou","year":"2006","unstructured":"Theodoridou A, Kartsios C, Yiannaki E, Markala D, Settas L (2006) Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy. Rheumatol Int 27(2):201\u2013202. https:\/\/doi.org\/10.1007\/s00296-006-0179-3","journal-title":"Rheumatol Int"},{"issue":"10","key":"4192_CR24","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","volume":"126","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB (2006) The risk of lymphoma in patients with psoriasis. J Invest Dermatol 126(10):2194\u20132201. https:\/\/doi.org\/10.1038\/sj.jid.5700410","journal-title":"J Invest Dermatol"},{"issue":"5","key":"4192_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jaad.2017.07.013","volume":"77","author":"D Fiorentino","year":"2017","unstructured":"Fiorentino D, Ho V, Lebwohl MG, Leite L, Hopkins L, Galindo C, Goyal K, Langholff W, Fakharzadeh S, Srivastava B, Langley RG (2017) Risk of malignancy with systemic psoriasis treatment in the psoriasis longitudinal assessment registry. J Am Acad Dermatol 77(5):845\u2013854e5. https:\/\/doi.org\/10.1016\/j.jaad.2017.07.013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4192_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2016.03.037","volume":"151","author":"E Shelton","year":"2016","unstructured":"Shelton E, Laharie D, Scott FI, Mamtani R, Lewis JD, Colombel JF, Ananthakrishnan AN (2016) Cancer recurrence following Immune-Suppressive therapies in patients with Immune-Mediated diseases: A systematic review and Meta-analysis. Gastroenterology 151(1):97\u2013109e4. https:\/\/doi.org\/10.1053\/j.gastro.2016.03.037","journal-title":"Gastroenterology"},{"issue":"1","key":"4192_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10238-018-0538-x","volume":"19","author":"P Paliogiannis","year":"2019","unstructured":"Paliogiannis P, Satta R, Deligia G, Farina G, Bassu S, Mangoni AA, Carru C, Zinellu A (2019) Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: A systematic review and meta-analysis. Clin Exp Med 19(1):37\u201345. https:\/\/doi.org\/10.1007\/s10238-018-0538-x","journal-title":"Clin Exp Med"},{"issue":"2","key":"4192_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5336\/dermato.2015-47752","volume":"26","author":"A \u00c7erman","year":"2016","unstructured":"\u00c7erman A, Karabay A, Altunay \u0130K (2016) Ps\u00f6riyazisli Hastalarda Sistemik Tedaviye verilen Yan\u0131t\u0131n C-Reaktif protein ve N\u00f6trofil-Lenfosit Oran\u0131 Ile \u0130li\u015fkisinin de\u011ferlendirilmesi: \u00f6n \u00c7al\u0131\u015fma. Turkiye Klinikleri J Dermatol 26(2):71\u201375. https:\/\/doi.org\/10.5336\/dermato.2015-47752","journal-title":"Turkiye Klinikleri J Dermatol"},{"issue":"3","key":"4192_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","volume":"29","author":"F Canpolat","year":"2010","unstructured":"Canpolat F, Akp\u0131nar H, Eskio\u011flu F (2010) Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 29(3):325\u2013328. https:\/\/doi.org\/10.1007\/s10067-009-1323-8","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4192_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5114\/ada.2016.61603","volume":"33","author":"S I\u015fik","year":"2016","unstructured":"I\u015fik S, K\u0131l\u0131\u00e7 S, \u00d6\u011fretmen Z, \u00c7ak\u0131r D\u00dc, T\u00fcrk\u00f6n H, Cevizci S, H\u0131z MM (2016) The correlation between the psoriasis area severity index and ischemia-modified albumin, mean platelet volume levels in patients with psoriasis. Adv Dermatol Allergol 33(4):290\u2013293. https:\/\/doi.org\/10.5114\/ada.2016.61603","journal-title":"Adv Dermatol Allergol"},{"issue":"3","key":"4192_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/1346-8138.14145","volume":"45","author":"CY Ng","year":"2018","unstructured":"Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH (2018) Metabolic parameters in psoriatic patients treated with interleukin-12\/23 Blockade (ustekinumab). J Dermatol 45(3):309\u2013313. https:\/\/doi.org\/10.1111\/1346-8138.14145","journal-title":"J Dermatol"},{"issue":"3","key":"4192_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4161\/derm.22074","volume":"4","author":"T Tzellos","year":"2012","unstructured":"Tzellos T, Kyrgidis A, Trigoni A, Zouboulis CC (2012) Association of ustekinumab and briakinumab with major adverse cardiovascular events: an appraisal of meta-analyses and industry sponsored pooled analyses to date. Dermatoendocrinol 4(3):320\u2013323. https:\/\/doi.org\/10.4161\/derm.22074","journal-title":"Dermatoendocrinol"},{"issue":"2","key":"4192_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.diabres.2011.07.037","volume":"94","author":"M Mishra","year":"2011","unstructured":"Mishra M, Kumar H, Bajpai S, Singh RK, Tripathi K (2011) Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, Proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract 94(2):255\u2013261. https:\/\/doi.org\/10.1016\/j.diabres.2011.07.037","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04192-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T12:05:14Z","timestamp":1744373114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4192"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04192-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Manisa Celal Bayar University Clinical Research Ethics Committee (reference number: 85252386-050.04.04, date: 07.10.2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this was a retrospective study using anonymized patient data, the requirement for informed consent was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"692"}}